Greta Brunet is an accomplished and results-oriented business leader with deep expertise in the life sciences and healthcare sectors. She has a proven track record
supporting the growth and success of startups and emerging companies, providing strategic guidance across therapeutics, diagnostics, devices, and digital health/HCIT.

Greta’s work spans funding program management, portfolio strategy, and the development and implementation of innovation initiatives that foster collaboration among health systems, investors, and clinical innovators.

As the founder and principal of CatalyzeMed (formerly Rx Strategic Solutions), Greta has consulted with early-stage ventures through to commercial-stage companies, offering data-driven insights on corporate development, business development and licensing, commercial strategy, market intelligence, and new product planning. She has been recognized for her ability to source and evaluate investment opportunities, conduct rigorous due diligence, and advise leadership teams on business strategy, planning, and fundraising. Greta is also skilled in cultivating strategic partnerships, engaging with investors and corporate strategics, and building networks that connect entrepreneurs to key ecosystem resources.

Her background includes hands-on clinical experience as a Physician Associate in family and internal medicine, as well as leadership roles in corporate and commercial development within the pharmaceutical industry. Greta’s expertise extends to strategic marketing, market assessments, business-case development, and analytics, with a strong record of driving innovation and growth.

Greta holds a BA in Psychology from Siena University, a certificate with honors from the Wake Forest University School of Medicine Physician Associate Program, and an MBA in corporate finance and general management from the Wake Forest University School
of Business. She is the recipient of the Triangle Business Journal’s Healthcare Leadership Award 2024, recognizing her leadership and impact in healthcare innovation.